Table 4 Anti-osteoporotic treatment in patients undergoing spinal surgery prior and recommendation after evaluation of bone mineral status
From: A retrospective analysis of bone mineral status in patients requiring spinal surgery
| Â | Prior to Evaluation | Recommendation |
|---|---|---|
| Â | n (%) | n (%) |
Basic therapy | ||
 Vitamin D supplementation | 57 (39.6%) | 144 (100%) |
 Adequate vitamin D supplementation (25-OH-D within recommended range) | 28 (19.4%) |  |
 Calcium supplementation | 31 (21.5%) | 20 (13.9%) |
Specific anti-osteoporotic treatment | 16 (11.1%) | 70 (48.6%) |
 Bisphosphonate (oral) | 8 (5.6%) | 26 (18%) |
 Bisphosphonate (intravenous) | 0 (0%) | 14 (9.7%) |
 Denosumab | 8 (5.6%) | 25 (17.3%) |
 Teriparatide | 0 (0%) | 5 (3.5%) |
Indication for specific treatment without therapy | 54 (37.5%) | Â |